Search bioRxiv⌕ Search

Biology subjects

Vos, W.

Publications and source records attributed to Vos, W..

3 recordsLinked to original sources

CRISPR-Engineered hiPSC-derived Cardiomyocytes Reveal Divergent Responses to Loss and Defective Processing of A-type Lamins

A-type lamins are critical for nuclear integrity and mechanotransduction in cardiomyocytes, and their disruption is a major cause of inherited cardiomyopathy. To compare the consequences of lamin A/C loss versus defective lamin A maturation, we generated CRISPR/Cas9-edited hiPSC lines lacking LMNA or ZMPSTE24 and differentiated them into iPSC-derived cardiomyocytes. LMNA knockout caused progressive nuclear deformation, loss of culture stability, and contractile vulnerability in iCM. ZMPSTE24 knockout led to subtler nuclear abnormalities and reduced calcium transient activity, temporally correlating with prelamin A accrual. Transcriptomics profiling revealed aberrant mechanical responses in both LMNA and ZMPSTE24 bi-allelic knockouts as well as unique perturbations in inflammatory signaling and epigenetic pathways. Interestingly, both knockout models shared a marked defect in proteostasis, as confirmed by reduced proteasome activity. Together, these results show that loss of lamin A/C and accumulation of prelamin A trigger both converging and distinct cardiomyocyte stress responses. In addition, the newly generated models offer an attractive platform to study lamin-associated cardiomyopathy and its therapeutic targeting.

Cell Biology↗

Viral persistence and antiretroviral therapy shape systemic immune aging in treated HIV infection

Chronic infections can reshape immune system homeostasis, yet how persistent viral infections influence immune aging remains poorly understood. People living with HIV provide a unique model to investigate how long-term viral persistence affects immune aging despite effective antiretroviral therapy. Here, we characterize immune aging by integrating plasma proteomics with epigenetic and transcriptional profiles of circulating immune cells across large cohorts of treated individuals with HIV. We find that immune aging is markedly accelerated compared with healthy individuals and parallels established DNA methylation-based aging clocks. Accelerated immune aging is strongly associated with signatures of immunosenescence and correlates with the size of the latent HIV reservoir, suggesting a persistent imprint of viral persistence on immune aging trajectories. Notably, exposure to specific antiretroviral agents, particularly nucleoside reverse transcriptase inhibitors, is associated with reduced immune aging and suppression of age-associated immune gene programs. Together, these findings identify chronic viral persistence as a driver of systemic immune aging and indicate that antiretroviral therapy can partially modulate immune aging programs.

immunology↗

Evaluation of folliculin detection by immunohistochemistry in Birt-Hogg-Dube associated kidney tumors

Germline inactivating mutations in folliculin (FLCN) cause Birt-Hogg-Dube (BHD) syndrome, a rare autosomal dominant disorder predisposing to kidney tumors. Kidney tumors associated with BHD typically lack FLCN expression due to loss of heterozygosity. In this study we assessed the potential of four commercial anti-FLCN antibodies for immunohistochemistry, as currently no routine diagnostic FLCN stainings are performed in the clinic. Despite comprehensive testing, we could not identify a commercial anti-FLCN antibody that is reproducibly effective in immunohistochemical analyses of formalin-fixed paraffin-embedded tissue material. We propose that dedicated future efforts are required to develop a suitable antibody for diagnostic immunohistochemical stainings. The inclusion of FLCN expression status as part of standard renal tumor pathology may contribute to better analyses of the molecular pathology of BHD tumors and facilitate identification of BHD patients, improve their (genetic and clinical) counseling, and enable genetic testing of at risk relatives.

genetics↗